Cancer immune contexture and immunotherapy
- PMID: 26708937
- DOI: 10.1016/j.coi.2015.11.009
Cancer immune contexture and immunotherapy
Abstract
The immune contexture that characterizes the density, the location, the organization and the functional orientation of tumor-infiltrating immune cells in cancers has a clinical impact on patient's outcome. It is, in great part, shaped by the malignant cells, as in a given cancer type, tumors presenting different oncogenic processes have different immune contextures. Moreover, the immune contexture in metastatic sites reflects that of the corresponding primary tumors. Finally, the components forming the immune contexture represent targets and markers of efficient anti-cancer immunotherapies.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.Adv Immunol. 2016;130:95-190. doi: 10.1016/bs.ai.2015.12.002. Epub 2016 Jan 29. Adv Immunol. 2016. PMID: 26923001 Review.
-
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.J Thorac Oncol. 2016 Jun;11(6):789-800. doi: 10.1016/j.jtho.2016.01.015. Epub 2016 Feb 1. J Thorac Oncol. 2016. PMID: 26845192 Review.
-
The immune contexture in cancer prognosis and treatment.Nat Rev Clin Oncol. 2017 Dec;14(12):717-734. doi: 10.1038/nrclinonc.2017.101. Epub 2017 Jul 25. Nat Rev Clin Oncol. 2017. PMID: 28741618 Review.
-
The immune contexture of primary and metastatic human tumours.Curr Opin Immunol. 2014 Apr;27:8-15. doi: 10.1016/j.coi.2014.01.001. Epub 2014 Feb 1. Curr Opin Immunol. 2014. PMID: 24487185 Review.
-
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.Cancer Commun (Lond). 2019 Apr 18;39(1):21. doi: 10.1186/s40880-019-0365-9. Cancer Commun (Lond). 2019. PMID: 30999966 Free PMC article. Review.
Cited by
-
Comprehensive analysis of ADGRE5 gene in human tumors: Clinical relevance, prognostic implications, and potential for personalized immunotherapy.Heliyon. 2024 Mar 7;10(6):e27459. doi: 10.1016/j.heliyon.2024.e27459. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38501000 Free PMC article.
-
Perioperative treatment with tranexamic acid in melanoma (PRIME): protocol for a Danish multicentre randomised controlled trial investigating the prognostic and treatment-related impact of the plasminogen-plasmin pathway.BMJ Open. 2024 Feb 2;14(2):e077012. doi: 10.1136/bmjopen-2023-077012. BMJ Open. 2024. PMID: 38309757 Free PMC article.
-
E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer.Medicine (Baltimore). 2024 Jan 12;103(2):e35722. doi: 10.1097/MD.0000000000035722. Medicine (Baltimore). 2024. PMID: 38215110 Free PMC article.
-
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities.Biomark Res. 2024 Jan 7;12(1):1. doi: 10.1186/s40364-023-00549-7. Biomark Res. 2024. PMID: 38185636 Free PMC article. Review.
-
Establishment of a prognostic signature for patients with advanced lung squamous cell carcinoma based on tumor-infiltrating immune cells.Transl Cancer Res. 2023 Oct 31;12(10):2706-2716. doi: 10.21037/tcr-23-545. Epub 2023 Oct 20. Transl Cancer Res. 2023. PMID: 37969402 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources

